Evinacumab Cuts LDL-C in Children With Homozygous Familial Hypercholesterolemia
Evinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3
LDL-C
Prevalence of Heart Failure Has Remained Stable Over the Last 2 Decades in the United States
A study was conducted to evaluate heart failure prevalence trends in the general adult US population during the past 2 decades.
Coronary Plaque Volumes, HDL Cholesterol, and Total Cholesterol to HDL Ratio
Researchers assessed the relationship between coronary artery plaque burden and HDL-C level and total cholesterol to HDL ratio.
Patients With Familial Hypercholesterolemia Face Overlap in Barriers, Facilitators for Care
A team of researchers examined the barriers and facilitators related to familial hypercholesterolemia care, pertaining to identification, cascade testing, and treatment.
Is More Aggressive Lipid-Lowering Therapy Needed in STEMI?
Are patients hospitalized with ST-elevated myocardial infarction adequately evaluated for cholesterol levels or other lipid disorders during their hospitalization?
FCHL and FH Associated With Increased and Similar Coronary Artery Disease Risk
Researchers investigated the relationship between cardiovascular risk and the genetic architecture of familial combined hyperlipidemia.
Sex Disparities in Treatment, Lipid Level Targets in Familial Hypercholesterolemia
A study was conducted to determine if there are sex disparities in lipid level target achievement and treatment in patients with familial hypercholesterolemia.
Long-Term Safety and Efficacy of Bempedoic Acid for Lowering LDL-C in ASCVD, HeFH
A study was conducted to determine the efficacy and long-term safety of bempedoic acid for treatment of ASCVD and HeFH.
Panel Addresses Ezetimibe, PCSK9 Inhibitors for Reducing CV Events
Guideline shifts focus from emphasis on LDL cholesterol targets to individualized approach for lowering overall cardiovascular risk.
Longitudinal LDL-C and Risk Associated With a Familial Hypercholesterolemia Genetic Variant
Researchers examined the effect of genetic testing for familial hypercholesterolemia variants with consideration of longitudinal LDL-C on risk stratification for patients.
- Loading...
Loading...
Loading... 
Loading...